INBS Stock Analysis: Buy, Sell, or Hold?
INBS - Intelligent Bio Solutions Inc. Common Stock
$7.41
-0.45 (-5.73%)
▼
5d:
-16.37%
30d:
-6.08%
90d:
+658.83%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Earnings: Feb 12, 2026
8d
Get Alerted When INBS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: INBS is down 16.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: INBS is down 16.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.40
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$6.46
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INBS is currently trading at $7.41, which is considered slightly low relative to its 30-day fair value range of $6.94 to $14.29. The stock's valuation (Forward PE: 21.2) is in line with its historical norms (21.2). At these levels, the market is pricing in -0.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INBS is in a strong uptrend. The price is currently testing key support at $7.20. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+61.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INBS is in a strong uptrend. The price is currently testing key support at $7.20. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+61.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$6.94 -
$14.29
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.7%)
- BULLISH: Trading 61.9% below Wall St target ($12.00)
- NEUTRAL: Market pricing in -0.0% annual earnings growth - fairly valued
- WARNING: Recommendation downgraded due to -16.4% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$6.94 -
$14.29
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$7.20
Resistance Level
$13.91
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
21.17
Wall Street Target
$12.00
(+61.9%)
Revenue Growth (YoY)
27.5%
PE vs Historical
21.2 vs 21.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
0%
(market-implied from PE analysis)
1-Year Target
$7.41
(0%)
2-Year Target
$7.41
(0%)
3-Year Target
$7.41
(0%)
3-Yr Target (if PE normalizes)
(PE: 21→21)
$7.42
(+0%)
Last updated: February 03, 2026 4:54 PM ET
Data refreshes hourly during market hours. Next update: 5:54 PM
Data refreshes hourly during market hours. Next update: 5:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 57 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 54 HOLD |